Medicare Enrolled

Dr. George Wooming, MD

Dermatology · Dallas, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
12200 PARK CENTRAL DRIVE, Dallas, TX 75251
9726615476
In practice since 2006 (20 years)
NPI: 1760457733 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wooming from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wooming? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wooming

Dr. George Wooming is a dermatology specialist in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wooming performed 4,164 Medicare services across 839 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wooming received a total of $23,910 from 45 pharmaceutical and/or device companies across 727 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wooming is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 29% volume in TX $23,910 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,164
Medicare services
Top 29% in TX for dermatology
839
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~208 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Photodynamic therapy gel for precancerous skin 2,600 $1 $5
Office visit, established patient (20-29 min) 511 $61 $150
Destruction of precancerous skin growths, 2-14 198 $5 $25
Destruction of precancer skin growth, 15 or more growths 164 $122 $300
Steroid injection (triamcinolone) 132 $1 $5
Destruction of skin growth, 15 or more growths 114 $95 $325
Destruction of skin growths (warts/lesions), 1-14 84 $79 $300
Destruction of precancerous skin growth, 1 57 $41 $135
Skin biopsy, tangential 52 $71 $150
Injection into skin growth, more than 7 growths 52 $49 $90
New patient office visit (30-44 min) 45 $62 $200
Office visit, established patient (30-39 min) 44 $92 $150
Injection into skin growth, 1-7 growths 41 $31 $80
Punch biopsy, first skin growth 36 $95 $150
Biopsy of related skin growth, each additional growth 21 $40 $150
Application of light with debridement to destroy precancer skin growth 13 $222 $654
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$23,910
Total received (2018-2024)
Avg $3,416/year across 7 years
Top 11% in TX for dermatology
45
Companies
727
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,439 (64.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,726 (23.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,744 (11.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,404
2023
$3,648
2022
$3,599
2021
$1,698
2020
$6,103
2019
$3,063
2018
$3,396

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$6,670
EPI Health, LLC
$1,541
Arcutis Biotherapeutics, Inc.
$1,391
Encore Dermatology Inc.
$1,248
Sun Pharmaceutical Industries Inc.
$1,114
GENZYME CORPORATION
$975
Regeneron Healthcare Solutions, Inc.
$910
ABBVIE INC.
$814
Lilly USA, LLC
$791
Ortho Dermatologics, a division of Bausch Health US, LLC
$728
Janssen Biotech, Inc.
$585
Galderma Laboratories, L.P.
$580
Almirall LLC
$511
Incyte Corporation
$472
AbbVie Inc.
$471
Amgen Inc.
$467
AbbVie, Inc.
$465
LEO Pharma Inc.
$464
SUN PHARMACEUTICAL INDUSTRIES INC.
$435
Dermavant Sciences, Inc.
$373
E.R. Squibb & Sons, L.L.C.
$369
Sandoz Inc.
$323
VYNE Pharmaceuticals Inc.
$255
MAYNE PHARMA INC.
$253
Novartis Pharmaceuticals Corporation
$234
Journey Medical Corporation
$175
Mayne Pharma Inc.
$138
UCB, Inc.
$130
Janssen Scientific Affairs, LLC
$125
Promius Pharma LLC
$120
SANOFI-AVENTIS U.S. LLC
$118
PruGen, Inc. Pharmaceuticals
$105
Biofrontera Inc.
$93
Medimetriks Pharmaceuticals, Inc.
$77
Exeltis, USA Inc.
$60
DERMIRA, INC.
$58
MAYNE PHARMA COMMERCIAL LLC
$53
Medtronic Vascular, Inc.
$53
Glenmark Therapeutics Inc.
$38
Celgene Corporation
$37
Sebela Pharmaceuticals Inc.
$24
Allergan, Inc.
$22
Aclaris Therapeutics, Inc.
$16
Allergan Inc.
$14
Taro Pharmaceuticals USA, Inc.
$12
Top 3 companies account for 40.2% of total payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Aczone · Ameluz · BOTOX · BRYHALI · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · Cloderm Cream · ClosureFast · Cordran · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIDEL · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Ecoza · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · JUBLIA EFINACONAZOLE · KERYDIN · Klisyri · LIBTAYO · LUZU LULICONAZOLE · Mupirocin Cream · Neosalus · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Odomzo · Otezla · PRAMOSONE · Promiseb Complete · QBREXZA · REMICADE · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · STELARA · Sernivo · Sernivo Spray · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TARGRETIN · TREMFYA · TRIANEX 0.05% · TWYNEO · TargaDox · Tovet (emollient formulation) · Tremfya · ULTRAVATE · USP) 0.1% · VTAMA · Veltin · WYNZORA · Winlevi · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (65%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $574 per 100 Medicare services performed
Looking for a dermatology specialist in Dallas?
Compare dermatologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
224
Per 100K population
8.6
County median income
$74,149
Nearest hospital
MEDICAL CITY GREEN OAKS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Wooming is a mixed practice specialist, with above-average Medicare volume (top 29% in TX), with low-engagement industry engagement in the top 11% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Wooming experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Wooming performed 2,600 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wooming receive payments from pharmaceutical companies?
Yes. Dr. Wooming received a total of $23,910 from 45 companies across 727 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wooming's costs compare to other dermatologists in Dallas?
Dr. Wooming's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wooming) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →